Dan Gorenstein is the senior reporter for Marketplace’s Health Desk, covering the business of healthcare.

Prior to Marketplace, Dan spent more than 11 years at New Hampshire Public Radio. He got his start in journalism at the Chicago Reporter; an investigative journal that examines race and class disparities in the Chicago area. He’s won numerous national and local awards, including the Society of Professional Journalist Sigma Delta Chi investigative reporting award.

You can follow him on Twitter at @dmgorenstein.

READ MORE

Features by Dan Gorenstein

The Obamacare charm offensive begins

The Affordable Care Act's PR push is gearing up for prime time.
Posted In: Affordable Care Act, health care, health care reform

U.S. releases data showing striking differences in hospital prices

The public can search a database for prices for 100 common procedures at every hospital in the country, opening a window onto price differences.
Posted In: health care, hospital

What's behind the slow rise of health care costs? Our pocketbooks

Health care costs have been rising at a slower rate for the last four years. Why? Hint: The answer is not the recession.
Posted In: health care, recession

Pfizer wants you to buy Viagra online -- from Pfizer

Viagra is one of the most-counterfeited drugs on the web, and Pfizer's latest effort to tackle that issue is a first.
Posted In: viagra, Pfizer, pharmaceuticals

Will you buy into Obamacare or pay the penalty?

The new health care law requires individuals to carry health insurance beginning next year, or pay a small fine. Behavioral economists say even a little punishment may go a long way to get people to sign up.
Posted In: health care reform, health insurance

Being a leader in the midst of chaos: How one Boston business is coping the day after

The day after bombings at the Boston Marathon, one business is concentrated on what matters — their employees.
Posted In: boston marathon, boston

OxyContin's waiting game: Generic drug makers salivate while the FDA wants safer pills

OxyContin is supposed to come off patent and generic drug makers are excited. But, the FDA may put a stop to it all to wait for safer pills.
Posted In: oxycontin, Purdue Pharma, generic drugs, FDA

DNA sequencing celebrates its first decade

The anniversary brings with it a new and lucrative era of personalized medicine.
Posted In: dna

Genetics may be the next big thing in medicine, but at what cost?

Many believe genetics are the next big thing in medicine, but one question for this new era of personalized medicine is cost.
Posted In: cancer, Science, genetics, health care

President Obama looks to reduce Social Security cost of living increases with 'chained CPI'

President Obama's new budget proposal -- which will be formally unveiled next week -- includes a move to slow payments to Social Security.
Posted In: Obama, federal budget, Social Security

Pages

 
 
With Generous Support From...